Insight Molecular Diagnostics Inc. (IMDX)

NASDAQ: IMDX · Real-Time Price · USD

Compare

7.32

+0.63 (9.42%)

At close: Feb 6, 2026, 4:00 PM EST

7.37

+0.05 (0.68%)

After-hours: Feb 6, 2026, 4:10 PM EST

IMDX Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	18.69	8.64	9.43	19.99	32.95	7.14
Short-Term Investments	-	-	-	0.43	0.9	0.68
Cash & Short-Term Investments	18.69	8.64	9.43	20.43	33.85	7.82
Cash Growth	455.81%	-8.44%	-53.82%	-39.66%	333.00%	-65.18%
Receivables	0.26	1.61	0.48	2.01	1.44	0.2
Inventory	0.47	0.41	-	-	-	-
Prepaid Expenses	1.24	0.82	0.64	0.98	0.9	0.26
Other Current Assets	-	0.28	0.14	2.12	2.95	0.94
Total Current Assets	21.39	11.76	10.7	25.54	39.14	9.23
Property, Plant & Equipment	6.49	6.32	5.44	10.85	8.37	6.52
Long-Term Investments	-	-	-	-	-	13.42
Goodwill	-	-	-	-	18.68	9.19
Other Intangible Assets	14.6	14.61	56.6	61.63	61.72	15.01
Other Long-Term Assets	1.46	2.39	2.16	2.07	31.65	2.06
Total Assets	43.94	35.08	74.89	100.09	159.56	55.42
Accounts Payable	1.06	2.28	0.95	1.25	1.81	0.43
Accrued Expenses	3.95	3.47	3.22	5.61	4.91	5.75
Current Portion of Long-Term Debt	-	-	-	-	1.31	2.39
Current Portion of Leases	1.6	1.3	0.67	0.82	0.82	0.42
Other Current Liabilities	1.06	0.23	2.36	4.43	5.27	-
Total Current Liabilities	7.66	7.28	7.19	12.11	14.12	9
Long-Term Debt	-	-	-	-	-	1.51
Long-Term Leases	1.53	2.37	2.2	2.73	3.55	4.31
Other Long-Term Liabilities	43.94	37.71	39.9	45.66	76.68	7.12
Total Liabilities	53.13	47.36	49.3	60.5	94.35	21.94
Common Stock	368.52	338.24	310.3	294.93	252.95	157.16
Retained Earnings	-377.81	-350.54	-289.88	-260.68	-187.77	-123.68
Comprehensive Income & Other	0.09	0.02	0.05	0.04	0.04	-
Total Common Equity	-9.2	-12.27	20.47	34.29	65.22	33.48
Shareholders' Equity	-9.2	-12.27	25.59	39.59	65.22	33.48
Total Liabilities & Equity	43.94	35.08	74.89	100.09	159.56	55.42
Total Debt	3.13	3.66	2.87	3.54	5.68	8.63
Net Cash (Debt)	15.57	4.97	6.56	16.88	28.18	-0.81
Net Cash Growth	-	-24.24%	-61.12%	-40.08%	-	-
Net Cash Per Share	0.58	0.38	0.86	3.05	6.34	-0.25
Filing Date Shares Outstanding	28.66	28.6	8.27	5.93	4.61	4.45
Total Common Shares Outstanding	28.63	17.45	8.26	5.93	4.61	3.46
Working Capital	13.73	4.48	3.5	13.43	25.02	0.23
Book Value Per Share	-0.32	-0.70	2.48	5.78	14.14	9.69
Tangible Book Value	-23.8	-26.88	-36.13	-27.34	-15.19	9.29
Tangible Book Value Per Share	-0.83	-1.54	-4.37	-4.61	-3.29	2.69
Machinery	9.89	8.37	6.91	9.41	6.29	2.48
Construction In Progress	0.69	0.34	0.73	2.14	1.24	2.09

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q